Sadly, few of the approximately 30% of endometriosis sufferers who eventually need follow-up surgery after diagnosis (once ...

- Medtech expert to drive commercialization of BioHealx ® for the treatment of anal fistula. - Pivotal milestone follows U.S. FDA De Novo clearance for BioHealx ® in 2024. GALWAY, Ireland, March ...

Version 1.0 System Integration Complete; Progressing Towards First Clinical Use Achieved 2024 Cash Burn Guidance; Sets 2025 Cash Burn Guidance of $50 Million WALTHAM, Mass., March 17, 2025 ...

The wife of a man whose face caught on fire after medical staff at Oregon Health & Science University allegedly failed to allow alcohol that was swabbed onto his face to dry before surgery has ...

Carol Burns, CEO, Signum Surgical, commented: “I am delighted to join the Signum Surgical team to lead its next phase of growth. This innovative technology is the first treatment of fistula-in ...

- Medtech expert to drive commercialization of BioHealx ® for the treatment of anal fistula. GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, (‘Signum’ or ‘the Company’) the medical ...

- Medtech expert to drive commercialization of BioHealx ® for the treatment of anal fistula. - Pivotal milestone follows U.S. FDA De Novo clearance for BioHealx ® in 2024. GALWAY, Ireland, March 12, ...